A novel DRD2 single-nucleotide polymorphism associated with schizophrenia predicts age of onset: HapMap Tag-single-nucleotide polymorphism analysis

Genetic Testing and Molecular Biomarkers

Volumn 16, Issue 2, 2012, Pages 77-81

  Voisey, Joanne ^a   Swagell, Christopher D ^a   Hughes, Ian P ^a   Lawford, Bruce R ^a,b   Young, Ross McD ^a   Morris, Charles Phillip ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HAPLOTYPE MAP; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; ONSET AGE; PREDICTION; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGE OF ONSET; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HAPMAP PROJECT; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, DOPAMINE D2; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84857523394     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2011.0085     Document Type: Article

References (28)

1. Abramson JH. (2004) WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Epidemiol Perspect Innov 1:6.
2. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th edition.
3. American Psychiatric Association, Washington, DC. Arinami T, Gao M, Hamaguchi H, et al. (1997) A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet 6:577-582.
4. Arinami T, Itokawa M, Enguchi H, et al. (1994) Association of dopamine D2 receptor molecular variant with schizophrenia. Lancet 343:703-704.
5. Benjamini Y, Hochberg Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 57:289-300.
6. Betcheva ET, Mushiroda T, Takahashi A, et al. (2009) Casecontrol association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population. J Hum Genet 54:98-107.
7. Carter KW, McCaskie PA, Palmer LJ (2006) JLIN: a Java based Linkage Disequilibrium plotter. BMC Bioinform 7:60.
8. Duan J, Wainwright MS, Comeron JM, et al. (2003) Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 12:205-216.
9. Dubertret C, Bardel C, Ramoz N, et al. (2010) A genetic schizophrenia-susceptibility region located between the ANKK1 and DRD2 genes. Prog Neuropsychopharmacol Biol Psychiatry 34:492-499.
10. Fan H, Zhang F, Xu Y, et al. (2010) An association study of DRD2 gene polymorphisms with schizophrenia in a Chinese Han population. Neurosci Lett 477:53-56.
11. Frazer KA, Ballinger DG, Cox DR, et al. (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449:851-861.
12. Glatt SJ, Faraone SV, Tsuang MT (2003) Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia. Mol Psychiatry 8:911-915.
13. Grandy DK, Litt M, Allen L, et al. (1989) The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. Am J Hum Genet 45:778-785.
14. Gupta M, Chauhan C, Bhatnagar P, et al. (2009) Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms. Pharmacogenomics 10:277-291.
15. Hanninen K, Katila H, Kampman O, et al. (2006) Association between the C957T polymorphism of the dopamine D2 receptor gene and schizophrenia. Neurosci Lett 407:195-198.
16. Hirvonen M, Laakso A, Nagren K, et al. (2005) C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo. Mol Psychiatry 10:889
17. Hoenicka J, Aragues M, Rodriguez-Jimenez R, et al. (2006) C957T DRD2 polymorphism is associated with schizophrenia in Spanish patients. Acta Psychiatr Scand 114:435-438.
18. Kukreti R, Tripathi S, Bhatnagar P, et al. (2006) Association of DRD2 gene variant with schizophrenia. Neurosci Lett 392: 68-71.
19. Lawford BR, Young RM, Swagell CD, et al. (2005) The C/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia. Schizophr Res 73:31-37.
20. Lewis CM, Levinson DF, Wise LH, et al. (2003) Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am J Hum Genet 73:34-48.
21. McGuffin P, Gottesman, II (1999) Risk factors for schizophrenia. N Engl J Med 341:370-371; author reply 372.
22. Monakhov M, Golimbet V, Abramova L, et al. (2008) Association study of three polymorphisms in the dopamine D2 receptor gene and schizophrenia in the Russian population. Schizophr Res 100:302-307.
23. Ott J (1988) Utility Programs for Analysis of Genetic Linkage, Program, HWE Version 1.10. Columbia University, New York.
24. Peralta V, Cuesta MJ (1994) Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia. Psychiatry Res 53:31-40.
25. Rasmussen HB, Timm S, Wang AG, et al. (2006) Association between the CCR5 32-bp deletion allele and late onset of schizophrenia. Am J Psychiatry 163:507-511.
26. SulliVan PF, Kendler KS, Neale MC (2003) Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 60:1187-1192.
27. Taft RJ, Pang KC, Mercer TR, et al. (2010) Non-coding RNAs: regulators of disease. J Pathol 220:126-139.
28. Zhang Y, Bertolino A, Fazio L, et al. (2007) Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci U S A 104:20552-20557.